Evidence map›Paper›PMID 41927485›Full record

ArticleProteins2026

In Silico Structure-Guided Design of Peptide Candidates Targeting γ-Secretase Subunit Assembly.

Selcen Arı Yuka, Kübra Telli, Alper Yılmaz

Abstract read
In one paragraph

Article in Proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Selcen Arı YukaDepartment of Bioengineering, Yildiz Technical University, Istanbul, Turkey.
Kübra TelliDepartment of Molecular Biology and Genetics, Istanbul Kultur University, Istanbul, Turkey.
Alper YılmazDepartment of Molecular Biology and Genetics, Yildiz Technical University, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The γ-secretase complex is a membrane-embedded protease essential for intramembrane cleavage of substrates such as Notch receptors and the amyloid precursor protein (APP), processes central to cancer progression and Alzheimer's disease (AD) pathology. However, catalytic inhibition of γ-secretase disrupts multiple signaling pathways, resulting in dose-limiting toxicities. In this study, we report a structure-guided approach to generate peptides with binding and stability profiles that disrupt the assembly of γ-secretase by targeting the interactions of Presenilin-1 and Nicastrin with APH1. First, molecular docking was performed for 36 248 peptides of varying lengths to assess their affinity scores to the PS1 and NCT interaction regions of APH1. Peptides filtered based on their affinity scores and physicochemical properties were then subjected to global molecular docking. 50-nanosecond molecular dynamics simulations and MM/PBSA analyses were performed on the top 10 potential candidates, identifying those with high dynamic interaction potential. Thus, seven γ-secretase inhibitor candidates with favorable affinity scores capable of providing stable interactions and thereby having the potential to disrupt the APH1:PS1 assembly were identified. This approach, which overcomes the challenges of targeting the transmembrane catalytic domain, is based on the inhibition of subunit assembly and presents promising candidates for future experimental studies.

Indexed as

Amyloid Precursor Protein SecretasesMembrane GlycoproteinsMembrane ProteinsPeptidesPresenilin-1Amino Acid SequenceBinding SitesDrug DesignEndopeptidasesHumansMolecular Docking SimulationMolecular Dynamics SimulationPeptide HydrolasesProtein BindingAmyloid Precursor Protein SecretasesAPH1A protein, humanEndopeptidasesMembrane GlycoproteinsMembrane Proteinsnicastrin proteinPeptide HydrolasesPeptidesPresenilin-1PSENEN protein, humanAPH1in silico peptide designmolecular dockingmolecular dynamics simulationsnotch signalingpeptide therapeuticsγ‐Secretase

Identifiers

PMID41927485
PMCPMC13327434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.